BusinessCompany NewsBioglan told adjust accounts

Bioglan told adjust accounts

Pharmaceutical company Bioglan Pharma has been asked by KPMG to adjust the accounts in its interim results.

In its introductory statement to its accounts, the company’s directors said KPMG had been unable ‘to reach definitive conclusion’ on its interims to July 31, 2001. KPMG confirmed it did not sign off these accounts.

They added: ‘Futher to its discussions with KPMG, and in the light of events which have occurred since 19 October, the board believe that it is appropriate to make a number of adjustments to the draft of interim results.’

The company reported its preliminary results earlier than scheduled in October, but said the results were ‘currently being reviewed by KPMG Audit’ and thus subject to change.

In September, Bioglan’s talks to acquire the skincare division of US pharmaceuticals company Myers Squibb collapse, prompting KPMG’s review and the subsequent request to adjust its accounts.

Since October the company has suffered a series of setbacks, including the termination of a development and licensing agreement with CeNeS pharmaceuticals and the sudden resignation of its acting finance director Ann Simon in November, the second in six months.

At the end of the revised interim results, KPMG said the directors were responsible for the financial information in the interim results, adding ‘we do not express an audito opinion of the financial information.’

The Big Five firm expressed its concerns over the group’s financing, which depends upon the renegotiation of Bioglan’s debt and its ability to continue operating as a going concern.

It said: ‘In view of the significance of this uncertainty, we consider that it should be drawn to your attention, but our conclusion is not qualified in this respect.’

They concluded: ‘As a result […] we are not able to draw any conculsions about the financial information as presented for the six months.’

Links

New Bioglan FD quits

Bioglan website

Related Articles

BDO replaces Deloitte as Mitie auditor

Audit BDO replaces Deloitte as Mitie auditor

3m Emma Smith, Managing Editor
CVR Global appoints partner in London office

Company News CVR Global appoints partner in London office

7m Alia Shoaib, Reporter
FTSE100 failing to provide adequate ethics information

Company News FTSE100 failing to provide adequate ethics information

7m Alia Shoaib, Reporter
Moore Stephens recruits new private client partner

Accounting Firms Moore Stephens recruits new private client partner

10m Emma Smith, Managing Editor
Magma Group announces merger, partner promotions

Accounting Firms Magma Group announces merger, partner promotions

10m Emma Smith, Managing Editor
BDO on ‘recruitment spree’ with multiple partner appointments

Accounting Firms BDO on ‘recruitment spree’ with multiple partner appointments

10m Emma Smith, Managing Editor
Brand strength leads to fee income growth for RSM

Accounting Firms Brand strength leads to fee income growth for RSM

10m Emma Smith, Managing Editor
Mazars strengthens audit team with partner appointment

Accounting Firms Mazars strengthens audit team with partner appointment

10m Emma Smith, Managing Editor